Group 1 - Jicheng Electronics won a total of 15 bids from the State Grid Corporation, with a total bid amount of approximately 215 million yuan, accounting for 8.27% of the company's projected revenue for 2024 [2] - Jianmin Group's chemical generic drug, Ambrutoro Oral Solution, has been approved for market launch by the National Medical Products Administration, aimed at treating cough and wheezing caused by chronic bronchitis and emphysema [3] - Taiji Industry's subsidiary plans to transfer accounts receivable not exceeding 85 million USD to optimize cash flow, with an expected service fee of approximately 285,000 USD [4] Group 2 - Nanjing Pharmaceutical's subsidiary plans to invest 398 million yuan in a modern pharmaceutical logistics expansion project, with a construction period of approximately 35 months [5] - Ruili Kemi received a development notification from a well-known domestic flying car company to supply core components [6] - Ding Tong Technology announced that several executives plan to reduce their holdings by a total of no more than 45,300 shares, representing about 0.032% of the total share capital [7][8] Group 3 - Ninghu Expressway's subsidiary plans to invest no more than 9.033 billion yuan in the construction of the Nanyang Yangtze River Bridge South Connection Project [10] - Wuliangye announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 25.78 yuan per 10 shares, totaling approximately 10 billion yuan [12] - Beixin Road and Bridge's subsidiary won a bid for a project worth 180 million yuan [14] Group 4 - Minhe Livestock reported a 7.75% month-on-month increase in sales revenue from commodity chick sales in November [15] - Xuelong Group plans to invest 100 million yuan to establish a wholly-owned subsidiary for vertical integration in the aluminum and magnesium technology sector [16] - Shengnong Development reported a 15.77% year-on-year increase in sales revenue in November, with significant growth in both poultry and processed meat products [17] Group 5 - Xingyu Co., Ltd. plans to repurchase shares worth 200 million to 300 million yuan for employee stock ownership plans [18] - Quan Chai Power intends to use 50 million yuan of idle funds to purchase structured deposit products [19] - Shibei High-tech appointed Zhao Junhong as the new deputy general manager [20] Group 6 - Fuan Pharmaceutical's subsidiary received a drug registration certificate for injectable isavuconazole, expanding its anti-infection product line [21] - Xiaoming Co. reported a 49.73% year-on-year decline in chicken product sales revenue in November [22] - Baiao Chemical adjusted its share repurchase price ceiling to no more than 48.95 yuan per share [23] Group 7 - Hefei China reported a 26.02% year-on-year decline in consolidated revenue for the first 11 months [24] - Laimei Pharmaceutical's subsidiary received medical device registration certificates for two endoscope products [25][26] - Xiantan Co. reported an 11.63% year-on-year increase in chicken product sales revenue in November [27] Group 8 - Qilin Security received government subsidies totaling 5.4014 million yuan [28] - Blue Sky Gas's controlling shareholder's 30.9134 million shares were judicially frozen, accounting for 4.33% of the total share capital [29] - Tieke Railway signed a contract for high-speed railway fasteners worth 654 million yuan, accounting for 41.08% of the company's projected revenue for 2024 [30] Group 9 - David Medical's electric surgical table received a medical device registration certificate [31] - Zhendong Pharmaceutical's affiliate's core product new drug application was accepted by the CDE [32] - Shanghai Pharmaceutical's apple acid sitagliptin tablet application for market approval was granted by the National Medical Products Administration [33] Group 10 - Nanjiao Food reported a 1.14% year-on-year increase in consolidated revenue for November [34]

Group 1 - The core viewpoint of the article is that Xiantan Co., Ltd. reported its chicken product sales revenue and quantity for November 2025, showing significant year-on-year and quarter-on-quarter changes [1] Group 2 - The company achieved chicken product sales revenue of 494 million yuan and sales volume of 57,400 tons, with year-on-year changes of 11.63% and 18.34% respectively [1] - The quarter-on-quarter changes in sales revenue and quantity were -1.79% and 1.89% respectively [1] Group 3 - In the poultry breeding and processing sector, the sales revenue was 431 million yuan with a sales volume of 52,900 tons [1] - In the food processing sector, the sales revenue was 62.86 million yuan with a sales volume of 4,500 tons [1]

Core Viewpoint - Xiantan Co., Ltd. reported a chicken product sales revenue of 494 million yuan for November 2025, with a year-on-year change of 11.63% and a month-on-month change of -1.79% [1] Group 1: Sales Performance - The sales volume for chicken products reached 57,400 tons in November 2025, reflecting a year-on-year increase of 18.34% and a month-on-month increase of 1.89% [1] Group 2: Project Development - The first phase of the prepared food project is progressing steadily in terms of research and development, brand building, and market sales [1] - The second phase of the project commenced production on July 17, 2024, with production capacity gradually being released [1] - The increase in production and processing volume is expected to lead to higher sales volume and revenue [1]

Core Insights - The company Xiantan Co., Ltd. (002746.SZ) reported a chicken product sales revenue of 493.64 million yuan for November 2025, with a sales volume of 57,400 tons, reflecting year-on-year changes of 11.63% and 18.34%, respectively, and quarter-on-quarter changes of -1.79% and 1.89% [1] Group 1: Poultry Farming and Processing Industry - The poultry farming and processing sector achieved chicken product sales revenue of 430.78 million yuan, with a sales volume of 52,900 tons, showing year-on-year changes of 5.20% and 14.33%, and quarter-on-quarter changes of -5.62% and 0.02% [1] - The pre-offset chicken product sales revenue was 465.38 million yuan, with a sales volume of 55,800 tons [1] Group 2: Food Processing Industry - The food processing sector reported chicken product sales revenue of 62.86 million yuan, with a sales volume of 4,500 tons, indicating significant year-on-year changes of 92.03% and 100.54%, and quarter-on-quarter changes of 35.97% and 30.29% [1]

山东仙坛集团股份有限公司 2025 年 11 月份销售情况简报 证券代码：002746 证券简称：仙坛股份 公告编号：2025-068 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、2025 年 11 月份销售情况简报 山东仙坛集团股份有限公司（以下简称"公司"）2025 年 11 月实现鸡肉产品 销售收入 49,364.35 万元，销售数量 5.74 万吨，同比变动幅度分别为 11.63%、 18.34%，环比变动幅度分别为-1.79%、1.89%。 其中，家禽饲养加工行业实现鸡肉产品销售收入 43,077.97 万元，销售数量 5.29 万吨（注：抵消前的鸡肉产品销售收入为 46,538.37 万元，销售数量 5.58 万吨），同比变动 5.20%、14.33%，环比变动-5.62%、0.02%；食品加工行业实现 鸡肉产品销售收入 6,286.38 万元，销售数量 0.45 万吨，同比变动 92.03%、 100.54%，环比变动 35.97%、30.29%。 上述数据未经审计，与定期报告披露的数据之间可能存在差异。因此上述数 据仅作为阶段性数据供投 ...

Core Viewpoint - The company reported a significant increase in chicken product sales revenue and quantity for November 2025, indicating positive growth trends in the poultry industry [1] Group 1: Sales Performance - The company achieved chicken product sales revenue of 493.64 million yuan, representing a year-on-year increase of 11.63% [1] - The sales quantity reached 57,400 tons, showing an 18.34% year-on-year increase [1] - On a month-on-month basis, sales revenue decreased by 1.79%, while sales quantity increased by 1.89% [1] Group 2: Segment Performance - Within the poultry farming and processing sector, sales revenue was 430.78 million yuan, with a sales quantity of 52,900 tons [1] - The food processing segment generated sales revenue of 62.86 million yuan, with a sales quantity of 4,500 tons [1] Group 3: Project Development - The company's first phase of the prepared food project is progressing steadily, and the second phase has been put into production, with capacity gradually being released [1]

证券时报·数据宝统计显示，仙坛股份今日收盘价为6.03元，下跌1.47%，日换手率为1.81%，成交额为 7807.53万元，全天主力资金净流入544.61万元，近5日该股累计下跌1.95%，近5日资金合计净流出 681.43万元。 两融数据显示，该股最新融资余额为1.76亿元，近5日增加27.17万元，增幅为0.15%。 据天眼查APP显示，山东仙坛集团股份有限公司成立于2001年06月14日，注册资本86053.8727万人民 币。（数据宝） 仙坛股份12月4日大宗交易平台出现一笔成交，成交量65.30万股，成交金额393.76万元，大宗交易成交 价为6.03元。该笔交易的买方营业部为机构专用，卖方营业部为中信证券股份有限公司上海分公司。 12月4日仙坛股份大宗交易一览 | 成交量（万 | 成交金额（万 | 成交价格 | 相对当日收盘折溢价 | 买方营 | 卖方营业部 | | --- | --- | --- | --- | --- | --- | | 股） | 元） | （元） | （%） | 业部 | | | 65.30 | 393.76 | 6.03 | 0.00 | 机构专 | 中信证券股份有限公司 ...

Market Overview - The aquaculture sector experienced a decline of 1.58% on November 21, with Huaying Agriculture leading the drop [1] - The Shanghai Composite Index closed at 3834.89, down 2.45%, while the Shenzhen Component Index closed at 12538.07, down 3.41% [1] Stock Performance - Huaying Agriculture (002321) closed at 3.24, down 10.00% with a trading volume of 1.5762 million shares and a turnover of 517 million yuan [1] - Tianyu Biological (603717) closed at 8.44, down 8.76% with a trading volume of 209,500 shares and a turnover of 180 million yuan [1] - Yike Food (301116) closed at 12.20, down 8.20% with a trading volume of 271,100 shares and a turnover of 338 million yuan [1] - Other notable declines include Fucheng Co. (600965) down 4.95%, Tianbang Food (002124) down 4.23%, and Dongrui Co. (001201) down 4.07% [1] Capital Flow - The aquaculture sector saw a net outflow of 572 million yuan from institutional investors, while retail investors contributed a net inflow of 261 million yuan [1] - The table of capital flow indicates that Xiaoming Co. (300967) had a net outflow of 912.89 million yuan from institutional investors [2] - Jingqi Zhino (000048) experienced a net inflow of 856.43 million yuan from institutional investors [2] - Shengnong Development (002299) had a net inflow of 134.24 million yuan from institutional investors [2]

Core Viewpoint - Xiantan Co., Ltd. experienced a decline of 1.54% in stock price on November 20, with a trading volume of 90.13 million yuan, indicating a potential market reaction to recent financial data and trading activities [1] Financing Summary - On November 20, Xiantan Co., Ltd. had a financing buy-in amount of 13.46 million yuan and a financing repayment of 13.37 million yuan, resulting in a net financing buy of 89,800 yuan [1] - The total financing and securities balance as of November 20 was 169 million yuan, which represents 3.06% of the circulating market value, indicating a low financing balance compared to the past year [1] - In terms of securities lending, 600 shares were repaid while 1,100 shares were sold, with a selling amount of 7,051 yuan, and the securities lending balance was 512,800 yuan, which is at a high level compared to the past year [1] Financial Performance - For the period from January to September 2025, Xiantan Co., Ltd. achieved an operating income of 4.139 billion yuan, reflecting a year-on-year growth of 8.72% [2] - The net profit attributable to the parent company for the same period was 193 million yuan, showing a significant year-on-year increase of 72.48% [2] Shareholder Information - As of September 30, 2025, the number of shareholders for Xiantan Co., Ltd. was 28,100, a decrease of 8.29% from the previous period, while the average circulating shares per person increased by 9.03% to 25,211 shares [2] - Since its A-share listing, Xiantan Co., Ltd. has distributed a total of 1.24 billion yuan in dividends, with 516 million yuan distributed over the past three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest with 17.98 million shares, an increase of 7.82 million shares from the previous period, while Guotai CSI Livestock Breeding ETF is a new entrant as the seventh largest shareholder with 11.38 million shares [3]

Core Points - Xiantan Co., Ltd. announced the change of its full company name, which does not affect its stock abbreviation or code [2] - The company completed the registration procedures for the name change with the market supervision administration and obtained a new business license [2] Summary by Category - **Company Name Change** - The company held the 15th meeting of the fifth board of directors and the second temporary shareholders' meeting on October 25 and November 12, 2025, respectively, to approve the proposal for changing the full company name [2] - The full name change has been officially registered and documented, with the new business license issued [2] - **Stock Information** - The stock abbreviation "Xiantan Co., Ltd." and the stock code "002746" remain unchanged despite the name change [2]